Back to News
AI
AstraZeneca strikes $40 million AI drug discovery deal with insitro
CNA·October 15, 2026·1 min read
AI Summary
AstraZeneca has partnered with AI biotech company insitro in a $40 million deal to discover and develop new treatments for challenging liver and heart conditions. The collaboration will leverage artificial intelligence to advance drug discovery efforts targeting these difficult-to-treat diseases.
From the source
LONDON, Oct 15 : AstraZeneca has teamed up with artificial intelligence biotech company insitro to discover and develop new treatments for difficult to treat liver and heart conditions, the British drugmaker said on Thursday.Under the agreement, AstraZeneca w…
The full text couldn't be loaded here (the source may require a subscription).
View original at CNAKeep reading
AI Deciphers Napoleon's Enigmatic Code and Ancient Papyri, Transforming Historical Researchsudouest.fr · 2h agoThe Next Leap in Public Services Starts Behind the Scenes - SAP News Centernews.sap.com · 2h agoArtificial intelligence for life-cycle-aware sustainable materials discovery - Naturenature.com · 2h agoNorth University of China's AI Education Lessons Recognized as Provincial Excellence Casesk.sina.com.cn · 2h ago
Was this useful?